Recruiting

Observational Study

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT06217783

Conditions

Oncologic Complications and Emergencies

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Introcan Safety IV Catheter

Study Details

Brief summary:

To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.

Conditions

Oncologic Complications and Emergencies

Study ID

NCT06217783

Start date

Mar 27, 2024

Status verified date

Jun, 2026

Completion date

Dec 1, 2027

Anticipated

Primary completion date

Dec 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Age > 18 years old.
2. Provision of signed and dated informed consent form.
3. Predetermined to have difficult IV access necessitating USIV placement
4. Expected admission to hospital with anticipated stay > 48 hours (per discussion with treating physician).

Exclusion Criteria:

1. Expected/anticipated discharge disposition from the ACCC (per discussion with treating physician).
2. Inability to give informed consent.
3. Pregnant women.
4. Non-English speaking participants.

Study Design

Enrollment

400 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: Group A

Participants will receive a catheter that is up to 1.75 inches long based on what the nurse thinks is best for you.

experimental: Group B

Participants will receive a catheter that is either 1.75 or 2.5 inches long based on what the nurse thinks is best for you.

Interventions

Introcan Safety IV Catheter

Given by IV

Primary outcome measure

  • Safety and adverse events (AEs) [ Time Frame: Through study completion; an average of 1 year. ]

Central Contacts and Locations

Central contacts

Jonathan Rowland, MD

(832) 450-8954jwrowland@mdanderson.org

Locations

MD Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Jonathan Rowland, MD

832-450-8954jwrowland@mdanderson.org

Principal Investigator:

Jonathan Rowland, MD

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Jun 23, 2026

Last verified

Jun, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-06-23.